Kanion Pharmaceutical Adds 8 Drugs to National Essential Medicines List

财中社··Read original
3▲1 ▼0Impact / 5
Summary · why it matters

Kanion Pharmaceutical announced that a total of 51 of its products have been included in the National Essential Medicines List, 2026 Edition, with 8 drugs newly added. In the first quarter of 2026, Kanion Pharmaceutical achieved revenue of 831 million yuan and net profit attributable to the parent company of 79.28 million yuan.

Impact on assets 1

Others▲ · 1 stocks
© 2026 MarketIVNews